Becton Dickinson Q2 FY26: where the revenue came from and where it went
The whole income statement of Becton Dickinson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 7, 2026
Revenue$4.71B
+5% year over year
Gross profit$2.15B
46% margin
Operating profit$0.09B
2% margin
Net profit−$0.31B
−7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 4.71 | 100% | +5% |
| Medical essentials | 1.65 | 35% | +5% |
| Interventional | 1.36 | 29% | +7% |
| Connected care | 1.12 | 24% | +5% |
| Bio pharma systems | 0.59 | 12% | +3% |
| Cost of revenue | −2.56 | 54% | |
| Gross profit | 2.15 | 46% margin | +4pp |
| R&D | −0.25 | 5% | +0pp |
| SG&A | −1.21 | 26% | +1pp |
| Other | −0.60 | 13% | +0pp |
| Operating profit | 0.09 | 2% margin | −7pp |
| Interest & other costs | −0.33 | ||
| Tax | −0.08 | ||
| Net profit | −0.31 | −7% margin | −13pp |
76 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest